Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

Publié en ligne: 25 avr. 2014

Pages: 163 - 172

Reçu: 12 oct. 2013

Accepté: 23 oct. 2013

DOI: https://doi.org/10.2478/raon-2013-0086

Mots clés

mesothelioma, pemetrexed, polymorphism, folate pathway, toxicity

© by Vita Dolzan

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.